Atorvastatin 10 mg plus ezetimibe versus titration to atorvastatin 40 mg: attainment of European and Canadian guideline lipid targets in high-risk subjects ≥65 years

2014

Background Few clinical studies have focused on the efficacy of lipid-lowering therapies in patients ≥65 years.

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

22

References

21

Citations